ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,612.80
0.00%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37538
0.15%
Bitcoin
62,141.58
-0.31%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) News

IOVA Iovance Biotherapeutics Inc

13.98
0.00 (0.00%)
Pre Market
Last Updated: 04:18:59
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 13.98 04:18:59
Open Price Low Price High Price Close Price Previous Close
13.98
more quote information »

Recent News

Date Time Source Heading
5/01/202405:01GLOBEIovance Biotherapeutics to Host First Quarter 2024 Financial..
4/30/202405:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
4/24/202415:01GLOBEIovance Biotherapeutics to Present Clinical and..
4/19/202416:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
3/22/202416:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
3/06/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202407:00EDGAR2Form 8-K - Current report
3/04/202405:30GLOBEIovance Biotherapeutics Announces FDA has Lifted Clinical..
3/01/202416:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
2/29/202406:30EDGAR2Form 8-K - Current report
2/28/202415:05EDGAR2Form 8-K - Current report
2/28/202415:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
2/22/202415:53EDGAR2Form 8-K - Current report
2/22/202407:45GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full-Year..
2/21/202415:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/20/202416:23EDGAR2Form 8-K - Current report
2/20/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202405:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of $211..
2/20/202405:03EDGAR2Form 8-K - Current report
2/16/202416:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
2/16/202414:38GLOBEIovance Biotherapeutics to Host Conference Call and Webcast..
2/16/202414:19GLOBEIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA..
2/14/202405:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/19/202416:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
1/18/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:03EDGAR2Form 8-K - Current report
12/28/202306:27IHMARKETNEWSWall Street Highlights: Amazon to Introduce Ads on Prime..
12/27/202316:00EDGAR2Form 8-K - Current report
12/27/202306:54DJNIovance Shares Fall Premarket As FDA Places Study On Hold..
12/27/202306:00GLOBEIovance Biotherapeutics Announces Clinical Program Update..
12/22/202316:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
11/17/202316:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
11/07/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:05EDGAR2Form 8-K - Current report
11/07/202315:01GLOBEIovance Biotherapeutics Reports Third Quarter and..
10/31/202315:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
10/31/202308:05GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
10/20/202316:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
10/18/202319:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/18/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/18/202319:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202307:15GLOBEIovance Biotherapeutics Announces Clinical Data for..

Your Recent History

NASDAQ
IOVA
Iovance Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved